drugset / Trial / NCT03039790
Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate descriptively the long-term immunogenicity of at least 1 NoV vaccine administration.
Timeline
- Start
- 2017-02-21
- Primary completion
- 2021-07-22
- Completion
- 2021-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NoV Vaccine | Vaccine | 15 ug | Intramuscular |
| Subject | NoV Vaccine | Vaccine | 50 ug | Intramuscular |
| Subject | NoV Vaccine | Vaccine | 150 ug | Intramuscular |
| Subject | NoV Vaccine | Vaccine | 167 ug | Intramuscular |
| Subject | NoV Vaccine | Vaccine | 500 ug | Intramuscular |